Pathogenesis of MAS is attributed to a patient’s underlying immune activity with studies showing elevated pro-inflammatory cytokines, most notably IL-6, IL-1β and IL-18 [25,26,27]. This evidence concerns the gene IL18 and macrophage activation syndrome.